You are currently browsing the archives for 26 December 2017.
Displaying 1 entry.

Announced today the use of the companys patented Endo-PAT2000 in BioMarin Pharmaceutical Inc.

Endo-PAT2000 adds an important dimension to the prevention of cardiovascular disease by enabling physicians to reliably detect endothelial function and modify patient management appropriately. Itamar Medical is certainly a medical technology organization developing non-invasive diagnostic systems using Peripheral Arterial Tone signal, including the Watch-PAT systems for the analysis of rest related breathing disorders and the Endo-PAT systems for assessment of endothelial function, a condition named an early stage of cardiovascular and cerebrovascular diseases..